论文信息 - Life-Threatening Adverse Reaction after Self-Initiated, Off-Label Use of High Dose Nicotinamide for the Treatment of Friedreich’s Ataxia

Life-Threatening Adverse Reaction after Self-Initiated, Off-Label Use of High Dose Nicotinamide for the Treatment of Friedreich’s Ataxia

A 40-year old woman, previously known for Friedreich’s ataxia, presented with shock, profound lactic acidosis and hepatic failure after ingestion of a high dose of nicotinamide, the amide form of vitamin B3. On her own initiative, she was taking up to 4.4 g per day of nicotinamide, after having learned the results of a phase 2 study suggesting a potential benefit in Friedreich’s ataxia. The outcome was good with supportive care and withdrawal of nicotinamide.

N. Garin | Pierre Arnold

[1] V. Libri,et al. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study , 2014, The Lancet.

[2] M. C. Lowe,et al. Metabolic acidosis, hypoglycemia, and severe myalgias: an attempt to mask urine drug screen results. , 2011, Pediatric emergency care.

[3] Ségolène Aymé,et al. Empowerment of patients: lessons from the rare diseases community , 2008, The Lancet.

[4] J. Perrone,et al. Toxicity from the use of niacin to beat urine drug screening. , 2007, Annals of emergency medicine.

[5] Richard A. Mularski,et al. Treatment Advice on the Internet Leads to a Life-Threatening Adverse Reaction: Hypotension Associated with Niacin Overdose , 2006, Clinical toxicology.